Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 1,852.61 | 1,945.23 | 1,199.94 | - |
Total Revenue | 1,852.61 | 1,945.23 | 1,199.94 | 0.00 |
Costof Revenue Total | 1,020.72 | 1,169.76 | 725.11 | - |
Gross Profit | 831.89 | 775.48 | 474.84 | - |
Selling/ General/ Admin Expenses Total | 437.48 | 415.43 | 105.57 | - |
Research Development | 83.70 | 139.61 | 58.16 | - |
Depreciation/ Amortization | 73.24 | 62.54 | 42.12 | - |
Other Operating Expenses Total | 0.00 | 3.65 | 0.74 | 0.00 |
Total Operating Expense | 1,539.80 | 1,665.33 | 879.35 | 0.00 |
Operating Income | 312.81 | 279.90 | 320.59 | 0.00 |
Interest Inc( Exp) Net- Non- Op Total | -129.37 | -174.46 | 21.44 | - |
Gain( Loss)on Saleof Assets | 0.19 | -4.47 | -1,557.46 | - |
Other Net | 0.60 | -1.23 | -11.61 | - |
Net Income Before Taxes | 300.49 | 260.77 | 155.38 | 0.00 |
Provisionfor Income Taxes | 83.59 | 67.28 | 33.13 | - |
Net Income After Taxes | 216.90 | 193.49 | 122.25 | 0.00 |
Net Income Before Extra Items | 216.90 | 193.49 | 122.25 | 0.00 |
Net Income | 216.90 | 193.49 | 122.25 | 0.00 |
Income Availableto Com Excl Extra Ord | 216.90 | 193.49 | 122.25 | 0.00 |
Income Availableto Com Incl Extra Ord | 216.90 | 193.49 | 122.25 | 0.00 |
Diluted Net Income | 216.90 | 193.49 | 122.25 | 0.00 |
Diluted Weighted Average Shares | 9.06 | 9.06 | 9.06 | 9.06 |
Diluted EPS Excluding Extra Ord Items | 23.93 | 21.35 | 13.49 | 0.00 |
DPS- Common Stock Primary Issue | 3.00 | - | 0.00 | 0.00 |
Diluted Normalized EPS | 23.93 | 21.39 | 27.01 | 0.00 |
Unusual Expense( Income) | - | 0.00 | - | - |
Aarti Pharmalabs Dividend Aarti Pharmalabs Bonus Aarti Pharmalabs News Aarti Pharmalabs AGM Aarti Pharmalabs Rights Aarti Pharmalabs Splits Aarti Pharmalabs Board Meetings Aarti Pharmalabs Key Metrics Aarti Pharmalabs Shareholdings Aarti Pharmalabs Balance Sheet Aarti Pharmalabs Cashflow Aarti Pharmalabs Q1 Results Aarti Pharmalabs Q2 Results Aarti Pharmalabs Q3 Results Aarti Pharmalabs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks